COVID-19 (Coronavirus): ADB Information Centre

Covid-19 vaccine safety- From bench to bedside « Back to Webinars

Within a year of the pandemic being announced, several COVID-19 vaccines were approved and administered to populations around the world. There have been various successes and challenges related to the development and deployment of COVID-19 vaccines and there is significant global interest in ensuring they are safe and effective. Healthcare professionals need credible information to build trust with their patients and answer their questions.

On Friday 21 May 2021 BMJ hosted a webinar exploring Covid-19 vaccine safety in clinical trials, post-authorization safety methods, and risk communication.

Speakers:

-Dr Patrick L. Osewe: Chief of Health Sector Group, Asian Development Bank
-Dr Stephen Prior, Microbiologist and President of Therax, Inc., USA
-Dr Daniel Salmon, Director of the Institute for Vaccine Safety, John Hopkins Bloomberg School of Public Health, USA
-Dr Priscilla Rupali, Infectious diseases physician and Professor Department of Infectious Diseases, Christian Medical College, Vellore, India

Moderated by Dr Kieran Walsh Clinical Director, BMJ

Webinar recording:
Speaker presentations

Dr Stephen Prior- clinical trials

Dr Dan Salmon- Post authorization safety

Dr Priscilla Rupali- Risk communication 

Webinar full report and exec summary

Full report

Exec summary

Cookie Settings